Causes and Management of Children Presenting With Macroscopic Hematuria in the Pediatric Emergency Department

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

100 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-09-30

Study Completion Date

2026-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Macroscopic hematuria. is a common symptom, leading to numerous emergency department visits in children of all ages.

It can be linked to many pathologies, and its management in the emergency department is not standardized.

Few articles describe the management of this symptom during pediatric emergency department visits.

Therefore, it is important to study this symptom and its management in order to establish a protocol.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Macroscopic Hematuria

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Macroscopic hematuria Hematuria in children

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

RETROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Minor subject (\<18 years old)
* Patient presenting to the pediatric emergency department with gross hematuria

Exclusion Criteria

\- Subject (and/or their parents) who expressed their opposition to participating in the study.

Maximum Eligible Age

17 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Service de Pédiatrie 1 - Réanimation - CHU de Strasbourg - France

Strasbourg, , France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Ariane ZALOSZYC, MD

Role: CONTACT

Phone: 33 3 88 12 77 42

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Ariane ZALOSZYC, MD, PhD

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

9456

Identifier Type: -

Identifier Source: org_study_id